149 related articles for article (PubMed ID: 6384307)
1. Epidermal nuclear immunofluorescence. Is it a specific marker for mixed connective tissue disease?
Kent LT; Hu CH; Michel B; Tan EM; Moskowitz RW
J Dermatol; 1984 Apr; 11(2):121-8. PubMed ID: 6384307
[No Abstract] [Full Text] [Related]
2. In-vivo epidermal nuclear reactions: a selective process.
Koelle MS; Kumar V; Beutner EH; Chorzelski TP
Br J Dermatol; 1991 Jul; 125(1):48-52. PubMed ID: 1873202
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
[TBL] [Abstract][Full Text] [Related]
4. Profiles of antinuclear antibodies in systemic rheumatic diseases.
Notman DD; Kurata N; Tan EM
Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
[TBL] [Abstract][Full Text] [Related]
5. [Mixed connective tissue disease (Sharp's syndrome)].
Müller W; Rosenthal M
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():744-50. PubMed ID: 306173
[No Abstract] [Full Text] [Related]
6. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
Levo Y; Lotan C
Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
[No Abstract] [Full Text] [Related]
7. [Detection of antinuclear antibodies using HEp-2 cells as nuclear substrates by the indirect immunofluorescent antibody technic].
Watanabe S; Miyawaki S
Rinsho Byori; 1987 Jan; 35(1):61-6. PubMed ID: 3550177
[No Abstract] [Full Text] [Related]
8. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
[TBL] [Abstract][Full Text] [Related]
9. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
Bambara LM; Biasi D; Caramaschi P; Codella O; Corrocher R; Serpelloni G; De Sandre G
Recenti Prog Med; 1985 Feb; 76(2):102-9. PubMed ID: 3887516
[No Abstract] [Full Text] [Related]
10. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
Appelboom T; Kahn MF; Peltier AP; de SEZE S
Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
[No Abstract] [Full Text] [Related]
11. [Autoantibodies in collagen diseases].
Meyer O
Ann Med Interne (Paris); 1986; 137(8):666-78. PubMed ID: 2436515
[No Abstract] [Full Text] [Related]
12. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
Parker MD; Turner RA
Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
[TBL] [Abstract][Full Text] [Related]
13. Combined titre and fluorescent pattern of IgG antinuclear antibodies using cultured cell monolayers in evaluating connective tissue diseases.
Parker MD; Kerby GP
Ann Rheum Dis; 1974 Sep; 33(5):465-72. PubMed ID: 4608364
[No Abstract] [Full Text] [Related]
14. [Subgroups of connective tissue disease].
Le Goff P; Youinou P
Presse Med; 1984 Nov; 13(42):2571-6. PubMed ID: 6239256
[TBL] [Abstract][Full Text] [Related]
15. [Detection of antibodies to extractable nuclear antigens with counterimmunoelectrophoresis and the Western blot technic].
Hauke G; Lührmann R; Metz B; Peter HH
Z Rheumatol; 1988; 47(1):26-9. PubMed ID: 3259356
[TBL] [Abstract][Full Text] [Related]
16. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
Maddison PJ; Mogavero H; Reichlin M
J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
[TBL] [Abstract][Full Text] [Related]
17. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
Peltier AP
Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
[No Abstract] [Full Text] [Related]
18. [Mechanisms underlying the development of speckled epidermal nuclear immunofluorescence in patients with high titer antibodies to RNP (author's transl)].
Iwatsuki K; Tagami H; Imaizumi S; Ginosa M; Yamada M
Nihon Hifuka Gakkai Zasshi; 1982 Mar; 92(4):515-8. PubMed ID: 7050472
[No Abstract] [Full Text] [Related]
19. Clinical significance of native DNA antibodies in systemic lupus erythematosus and other connective tissue diseases.
Webb J; Whaley K; Lee P
Scott Med J; 1974 Jul; 19(4):171-5. PubMed ID: 4209789
[No Abstract] [Full Text] [Related]
20. Identification of specific antibodies to extractable nuclear antigens by passive immunodiffusion.
Kozin F; Fowler M
Am J Clin Pathol; 1979 Apr; 71(4):437-40. PubMed ID: 108995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
